These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4551814)
41. Antidiuretic effect of clofibrate in therapy of diabetes insipidus. de Gennes JL; Bigorie B; Bertrand C; Truffert J Horm Metab Res; 1973 Nov; 5(6):461-6. PubMed ID: 4588116 [No Abstract] [Full Text] [Related]
42. Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials. Holme I Control Clin Trials; 1996 Feb; 17(1):13-22. PubMed ID: 8721798 [TBL] [Abstract][Full Text] [Related]
43. [Changes in myocardial perfusion in ischemic heart disease as affected by nitrong]. Kramer AA; Gasilin VS; Samoĭlenko LE Kardiologiia; 1980 Nov; 20(11):76-9. PubMed ID: 6777575 [TBL] [Abstract][Full Text] [Related]
44. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950 [No Abstract] [Full Text] [Related]
45. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease. Steele P; Battock D; Genton E Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247 [TBL] [Abstract][Full Text] [Related]
46. Trial of clofibrate. Dewar HA; Oliver MF Br Med J; 1972 Feb; 1(5798):506. PubMed ID: 5008064 [No Abstract] [Full Text] [Related]
47. General therapeutic and prophylactic problems in the treatment of atherosclerosis. Begg TB Acta Cardiol; 1972; ():Suppl 15:101-1. PubMed ID: 4583031 [No Abstract] [Full Text] [Related]
48. [Critical review of clinical experimentation with clofibrate in coronary disease]. Azzena D; Astengo F Minerva Cardioangiol; 1973; 21(7):497-502. PubMed ID: 4756344 [No Abstract] [Full Text] [Related]
49. Status of antiplatelet drugs in coronary heart disease. Mehta J; Mehta P JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365 [No Abstract] [Full Text] [Related]
50. Clofibrate for the treatment of occlusive cerebrovascular disease. Hirsch SB; Wechsler AF; Tourtellotte WW N Engl J Med; 1972 Sep; 287(13):671. PubMed ID: 4561834 [No Abstract] [Full Text] [Related]
51. Are agents affecting platelet function clinically useful in patients with coronary artery disease? Verstraete M Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523 [No Abstract] [Full Text] [Related]
52. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study. Bhatia ML; Setty KR; Roy SB J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418 [No Abstract] [Full Text] [Related]
53. Clofibrate and heart disease. N Z Med J; 1972 Jan; 75(476):26-7. PubMed ID: 4502628 [No Abstract] [Full Text] [Related]
54. The cardiovascular disease programme of WHO/EURO. A critical review of its first 12 years. Lamm G Eur Heart J; 1981 Aug; 2(4):269-80. PubMed ID: 7028485 [No Abstract] [Full Text] [Related]
55. Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S). Oliver MF Adv Exp Med Biol; 1972; 26(0):255-9. PubMed ID: 4679687 [No Abstract] [Full Text] [Related]
56. [Clinical experiences with the use of carbochromen in coronary syndrome]. Ivancić R; Persić T; Custović F Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580 [No Abstract] [Full Text] [Related]
57. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]
58. [Computerized analysis of the changes induced with nifedipine in the exercise ECG]. Visioli O; Manca C; Colla B; Albertini D; Dei Cas L Boll Soc Ital Cardiol; 1977; 22(7):1057-63. PubMed ID: 375952 [No Abstract] [Full Text] [Related]
59. [Clinical trial of the new coronary dilator hexobendine]. Henke C; Dudik E; Steim H Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101 [No Abstract] [Full Text] [Related]